Sawtooth Solutions, LLC Eli Lilly & CO Transaction History

Sawtooth Solutions, LLC

$3.64 Billion
Q4 2023

A detailed history of Sawtooth Solutions, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 48,079 shares of LLY stock, worth $38.3 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

48,079

Previous 47,971 0.23%

Holding current value

$38.3 Million

Previous $25.8 Million 8.77%

% of portfolio

0.77%

Previous 0.83%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $56,720 - $66,866	108 Added 0.23%	48,079 $28 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $3.26 Million - $4.49 Million	-7,498 Reduced 13.52%	47,971 $25.8 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $668,159 - $893,406	-1,905 Reduced 3.32%	55,469 $26 Million
Q1 2023 Apr 27, 2023	BUY	$310.63 - $364.82 $14.6 Million - $17.2 Million	47,055 Added 456.0%	57,374 $19.7 Million
Q4 2022 Feb 02, 2023	BUY	$321.55 - $374.67 $137,301 - $159,984	427 Added 4.32%	10,319 $3.78 Million
Q3 2022 Oct 12, 2022	BUY	$296.48 - $337.87 $271,872 - $309,826	917 Added 10.22%	9,892 $3.2 Million
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $402,764 - $472,905	1,445 Added 19.19%	8,975 $2.91 Million
Q1 2022 May 20, 2022	SELL	$234.69 - $291.66 $1.58 Million - $1.96 Million	-6,724 Reduced 47.17%	7,530 $2.16 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $1.84 Million - $2.28 Million	8,182 Added 134.75%	14,254 $3.94 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $191,905 - $236,166	866 Added 16.63%	6,072 $1.4 Million
Q2 2021 Sep 01, 2021	BUY	$180.55 - $233.54 $165,925 - $214,623	919 Added 21.44%	5,206 $1.2 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $108,944 - $141,033	-663 Reduced 13.39%	4,287 $801,000
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $80,624 - $106,685	618 Added 14.27%	4,950 $836,000
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $286,591 - $331,494	-1,960 Reduced 31.15%	4,332 $641,000
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $1.03 Million - $1.24 Million	-7,565 Reduced 54.59%	6,292 $1.03 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $219,052 - $271,124	1,840 Added 15.31%	13,857 $1.92 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $346,206 - $428,808	3,238 Added 36.88%	12,017 $1.58 Million
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $138,079 - $150,194	1,293 Added 17.27%	8,779 $982,000
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $11,854 - $13,837	-107 Reduced 1.41%	7,486 $829,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $67,899 - $79,922	610 Added 8.74%	7,593 $985,000
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $739,499 - $828,463	6,983 New	6,983 $808,000
Q3 2018 Oct 26, 2018	SELL	$85.86 - $107.31 $871,135 - $1.09 Million	-10,146 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $134,216 - $154,038	-1,773 Reduced 14.88%	10,146 $866,000
Q1 2018 May 08, 2018	BUY	$74.21 - $87.6 $884,508 - $1.04 Million	11,919 New	11,919 $922,000
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $988,576 - $1.1 Million	-12,827 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	12,827	12,827 $1.06 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.

Account

Sawtooth Solutions, LLC Eli Lilly & CO Transaction History